Tracking the 2015 Gastrointestinal Cancers Symposium: bridging cancer biology to clinical gastrointestinal oncology
نویسندگان
چکیده
منابع مشابه
Tracking the 2015 Gastrointestinal Cancers Symposium: bridging cancer biology to clinical gastrointestinal oncology
The 2015 Gastrointestinal Cancers Symposium (San Francisco, CA, USA; January 15-17) is the world-class conference co-sponsored by the American Society of Clinical Oncology, the American Society for Radiation Oncology, the American Gastroenterological Association Institute, and the Society of Surgical Oncology, in which the most innovative research results in digestive tract oncology are present...
متن کاملAdvancements in the Management of Pancreatic Cancer: 2015 ASCO Gastrointestinal Cancers Symposium (San Francisco, CA, USA. January 15-17, 2015).
Agent Response rate (RR) Median PFS Median OS #344 Pimasertib (Pim) + gemcitabine vs. Placebo + gemcitabine 9.1% both arms 3.7 months vs. 2.8 months (HR: 0.883, 95% CI: 0.549–1.42; P=0.608) 7.3 months vs. 8.3 months #336 IMM-101 + gemcitabine vs. gemcitabine monotherapy NR 4.4 months vs. 2.4 months (P=0.003) 7.2 months vs. 5.6 months
متن کاملImmunotherapy in Gastrointestinal Cancers
Gastrointestinal cancers represent a major public health problem worldwide. Immunotherapeutic strategies are currently under investigation in this setting and preliminary results of ongoing trials adopting checkpoint inhibitors are striking. Indeed, although a poor immunogenicity for GI has been reported, a strong biological rationale supports the development of immunotherapy in this field. The...
متن کاملOverview of Gastrointestinal Cancers
Cancers of the gastrointestinal (GI) tract include those of the esophagus, stomach, colon, rectum, and anus. Risk factors, incidence, prevalence, and prognosis vary for each site. Many of the risk factors are modifiable, and in a significant number of cases, the cancers are preventable with proper screening and curable when detected and treated at an early stage. Esophageal cancer is a treatabl...
متن کاملGastrointestinal stem cells and cancer: bridging the molecular gap.
Cancer is believed to be a disease involving stem cells. The digestive tract has a very high cancer prevalence partly owing to rapid epithelial cell turnover and exposure to dietary toxins. Work on the hereditary cancer syndromes including familial adenomatous polyposis (FAP) has led to significant advances, including the adenoma-carcinoma sequence. The initial mutation involved in this stepwis...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: OncoTargets and Therapy
سال: 2015
ISSN: 1178-6930
DOI: 10.2147/ott.s82624